Why Platform Technologies (iPaaS) Are Critical in the Life Sciences
Every industry has embraced the idea that digital technologies need to be fully integrated in the business processes to ensure successful competition. In the era of Industry 4.0, your organization’s data (digital assets) are now recognized as your most valuable assets. Within the life sciences, however, there are many constraints of the scientific operating environment, such as regulatory oversight, evolving digital technologies, the data integrity demanded by decision makers and regulators, and the remaining legacy technologies. All of these constraints, and more, have made it difficult for the life sciences industries to leverage the automation and efficiency that would come with modernizing their data lineages.
